Lung cancer and heart disease are leading killers worldwide. Detection of these conditions is complex and time-consuming. ClearRead™ CT is a cardiothoracic AI suite for pulmonary nodule and coronary artery calcification (CAC) analysis.
Proven to reduce total reading time by 36%1, a series of advanced AI algorithms are deployed that target complex and time-consuming tasks like nodule segmentation, characterization, and Agatston scoring. The unique and patented vessel suppression solution provides an unimpaired view of the lung for improved visualization of nodules. Pulmonary nodule findings are segmented, quantified, and prior exams are used for comparison. An Agatston score is calculated for CAC on ungated, non-contrast CTs.
ClearRead CT delivers proven accuracy, seamless workflow, and time-saving insights that ease cognitive burden and improve patient outcomes.
Schedule a demo to learn more about ClearRead CT.
1 Chorath, K., Tharp, K., Watt, C., Bresnahan, B. W., Medverd, J. R., Cross, N. M., & Chalian, H. (2024, December 4). Unveiling the impact of Riverain’s vessel suppression: Breakthrough or bust? [Scientific poster presentation]. RSNA 2024 Annual Meeting, Chicago, IL.